The gut-liver-kidney-brain axis in Wilson disease: copper speciation-flux and barrier-mediated organ crosstalk - Summary - MDSpire

The gut-liver-kidney-brain axis in Wilson disease: copper speciation-flux and barrier-mediated organ crosstalk

  • By

  • Nannan Qian

  • Sihuan Zhu

  • Yuqi Song

  • Yulong Yang

  • Han Wang

  • Hui Han

  • Guocun Xu

  • Wenjie Hao

  • Hailin Jiang

  • Yue Yang

  • Hu Xi

  • Yufeng Ding

  • Wei He

  • Taohua Wei

  • Wenming Yang

  • Ting Cheng

  • June 17, 2026

  • 0 min

Share

Objective:

To explore the multi-organ nature of Wilson disease (WD) and the dynamics of copper speciation and organ communication.

Approach:
    Key Findings:
    • WD is a multi-organ disorder with significant involvement of the gut, liver, kidneys, and brain.
    • Copper circulates in dynamic, bioactive pools that disrupt barrier structures and spread toxicity.
    • Gut dysbiosis exacerbates hepatic inflammation and copper retention.
    • Renal dysfunction and neurotoxicity are linked to copper species-dependent passage across biological barriers.
    Interpretation:

    Limitations:
    • The model requires further validation through clinical trials.
    • Current understanding of copper dynamics and inter-organ communication is still evolving, particularly regarding specific pathways.
    Conclusion:

Original Source(s)

The gut-liver-kidney-brain axis in Wilson disease: copper speciation-flux and barrier-mediated organ crosstalk

  • by Nannan Qian, Sihuan Zhu, Yuqi Song, Yulong Yang, Han Wang, Hui Han, Guocun Xu, Wenjie Hao, Hailin Jiang, Yue Yang, Hu Xi, Yufeng Ding, Wei He, Taohua Wei, Wenming Yang, Ting Cheng

  • June 17, 2026

Related Content

Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies

Editorial: Biomarkers and beyond: predicting course and tailoring treatment in inflammatory bowel diseases

Editorial: Community series in towards precision medicine for immune-mediated disorders: advances in using big data and artificial intelligence to understand heterogeneity in inflammatory responses, volume III